Herpes Zoster Following COVID-19 Vaccination.
J Drugs Dermatol
; 20(8): 898-900, 2021 Aug 01.
Article
in English
| MEDLINE | ID: covidwho-1359539
ABSTRACT
Vaccination is an important intervention in preventing the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Messenger RNA (mRNA) vaccines from Pfizer™ and Moderna™ are the first to market in the United States, and while cutaneous adverse events have been reported in clinical trials for both of these vaccines, they have not been well characterized. Here we report a case of a patient who developed herpes zoster after receiving the Moderna™ COVID-19 vaccine. Dermatologists should familiarize themselves with this and other potential cutaneous adverse events associated with COVID-19 vaccination. J Drugs Dermatol. 2021;20(8)898-900. doi10.36849/JDD.6146.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vaccination
/
COVID-19 Vaccines
/
COVID-19
/
Herpes Zoster
Type of study:
Case report
/
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
J Drugs Dermatol
Journal subject:
Dermatology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS